AlphaYouBG
Schedule 13G filing
Bellevue Group AG disclosed a 10.6% stake in Yarrow Bioscience, Inc. (YARW)
Bellevue Group AG reported owning 10.6% of Yarrow Bioscience, Inc. (YARW) (1,000,000 shares) in a Schedule 13G filed Oct 7, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 7, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.